Wobble Genomics
The company develops a full-length RNA sequencing platform designed to detect novel biomarkers from blood samples. Its technology focuses on transcriptome discovery, fusion genes, and immune activity to support applications in cancer medicine and precision medicine. The platform is utilized for biomarker discovery and development by researchers and clinical partners.
Visit websiteMidlothian, UK
Healthtech
Biotechnology
Precision Medicine
Oncology
Funding summary
- Total raised
- €9.9M
- Funding rounds
- 1
Investors in Wobble Genomics
Investors on record for Wobble Genomics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Wobble Genomics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors